SCHEMBL7974986

SCHEMBL7974986

C/C(=N\O)NCCCCC(NC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
CTSK P43235 8/20 0.47
CTSS P25774 5/20 0.47
FOLH1 Q04609 1/20 0.45
CAPN1 P07384 1/20 0.44
TDP1 Q9NUW8 2/20 0.42
TGM2 P21980 1/20 0.42
SIRT5 Q9NXA8 1/20 0.42
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
ATM Q13315 1/20 0.40
CXCR3 P49682 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7911811 1.00 MEN1 (0.50) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL7220466 1.00 MEN1 (0.50) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL16572108 0.89 MEN1 (0.47) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL16520528 0.89 MEN1 (0.47) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL2211809 0.88 FOLH1 (0.58) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL7718173 0.88 FOLH1 (0.58) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL12643955 0.88 FOLH1 (0.58) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL8193831 0.88 CYP1A2 (0.50) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL10241524 0.88 MEN1 (0.65) MEN1GAAKMT2AALDH1A1TSHR
SCHEMBL391537 0.88 MEN1 (0.65) MEN1GAAKMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001005748-A1 OLIGOMERIC AMINO ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS MONSANTO COMPANY (US) 2001-01-25 WO disclosed